Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Pharmafluidics NV maintains a patent portfolio focused on the Chemistry & Materials technology area. The company currently has 2 pending office actions distributed across 1 distinct art unit. This concentration suggests a specialized technical focus within the USPTO classification system, as all current prosecution activity is localized within a single administrative division. Practitioners should note that this singular art unit focus can lead to more predictable examination patterns compared to portfolios spread across multiple units.
Examination of the portfolio involves 2 distinct examiners. ALABI, OYELEYE A is identified as the busiest examiner for this company. This specific examiner is currently responsible for 1 pending office action. Because the workload is split between multiple examiners, the company experiences a variety of examiner perspectives even within its concentrated art unit footprint. The presence of the pending office actions indicates an active phase of prosecution for the company's intellectual property assets in the Chemistry & Materials sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALABI, OYELEYE A | 1 | 84.0% | +25.2% |
| GERHARD, ALISON CLAIRE | 1 | 39.5% | +24.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568613 | GENERIC DESIGN FOR MICROFLUIDIC APPARATUS | ALABI, OYELEYE A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18550253 | MICROFLUIDIC DEVICE | GERHARD, ALISON CLAIRE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568613 | GENERIC DESIGN FOR MICROFLUIDIC APPARATUS | ALABI, OYELEYE A | — |
| 18550253 | MICROFLUIDIC DEVICE | GERHARD, ALISON CLAIRE | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18568613 | GENERIC DESIGN FOR MICROFLUIDIC APPARATUS | ALABI, OYELEYE A | — | §103 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18550253 | MICROFLUIDIC DEVICE | GERHARD, ALISON CLAIRE | 1797 | §103§112 | Non-Final OA | — | Pending | Sep 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial